Timothy P. Walbert - Apr 5, 2023 Form 3 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Stock symbol
MIRM
Transactions as of
Apr 5, 2023
Transactions value $
$0
Form type
3
Date filed
4/6/2023, 06:58 PM
Previous filing
Jan 6, 2023
Next filing
Jun 14, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.